Replies to post #78551 on Biotech Values

[genisi]

CSL, Talecris terminate merger agreement

http://www.reuters.com/article/rbssHealthcareNews/idUSN0827865520090608

* Costs, distraction cited as reason to terminate merger

* CSL to pay $75 million breakup fee